This special issue from Drugsincontext.com contains a series of case studies about the experiences of women with vulvar and vaginal atrophy during treatment with ospemifene.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.